Search -

Displaying 101 - 120 of 123

Sort: Relevancy | Date

News Opinion Editor's Corner TCT 2016

TCT 2016: Inspiration and Perspiration Greet Left Main Stenting, Hoop Dreams, Valve Innovation, and Election Fever

Shelley Wood

October 24, 2016

News Daily News

Combining Off-Pump CABG and Transaortic TAVR May Be an Option in Some Cases

Todd Neale

July 14, 2016

News Daily News

Percutaneous Device-Based Closure Successful in Children with Ventricular Septal Defects

L.A. McKeown

November 14, 2012

News Daily News

El Cierre Percutáneo con ayuda de un Dispositivo tiene Éxito en Niños con Defectos Septales Ventriculares

L.A. McKeown

November 14, 2012

News Conference News EuroPCR 2012

TAVR Studies Tease Out Influences on Clinical Outcome

Caitlin E. Cox

May 18, 2012

News Daily News

TAVR Suitable Even in Patients with Impaired LVEF

Caitlin E. Cox

April 19, 2012

News Daily News

La TAVR es Apta Incluso para Pacientes con LVEF Deteriorada

Caitlin E. Cox

April 19, 2012

News Conference News ACC 2012

ACC-i2 Scientific Session 2012: Cooperation Key as Practice Changing Results Released

Yael L. Maxwell

April 02, 2012

News Daily News

TCTMD’s Top 10 Most Popular News Stories From 2011

Jason Kahn

March 08, 2012

News Daily News

Los 10 Artículos Más Populares de TCTMD de 2011

Jason Kahn

March 08, 2012

News Daily News

Percutaneous Valve Replacement Stakes Out the Tricuspid

March 06, 2012

News Daily News

Patient Selection Trends Younger, Less High Risk for Transcatheter Valve Therapy

March 06, 2012

News Daily News

La Sustitución Percutánea de Válvulas Apuesta por la Tricúspide

March 06, 2012

News Daily News

La Selección de Pacientes Seleccionados para recibir un Tratamiento de Válvula Transcateter son cada vez Más Jóvenes y de Menor Riesgo

March 06, 2012

News Daily News

Women Benefit From TAVR as Much as Men, Maybe More

Jason Kahn

January 29, 2012

News Daily News

Fewer Vascular Complications as TAVR Evolves

Caitlin E. Cox

January 10, 2012

Presentation TCT 2012

Predictive factors of major VARC vascular complications following trans-femoral transcatheter aortic valve implantation.

Presenter: Ilyes Kharrat, Nicolas Amabile, Said Ghostine, Alexandre Azmoun, Ramzi Ramadan, Remi Nottin, Christophe Caussin

January 03, 2012

News Industry News

FDA approves first artificial aortic heart valve placed without open-heart surgery

November 02, 2011

News Daily News

TAVI with CoreValve Effective, Safe at 2-Years, Though Mortality a Concern

Leah Lawrence

April 11, 2011

News Conference News

ACC Scientific Session-i2 Summit 2011: The Devil Is in the Details

Caitlin E. Cox

April 08, 2011

Advertisement

TCT 2016: Inspiration and Perspiration Greet Left Main Stenting, Hoop Dreams, Valve Innovation, and Election Fever

Combining Off-Pump CABG and Transaortic TAVR May Be an Option in Some Cases

Percutaneous Device-Based Closure Successful in Children with Ventricular Septal Defects

El Cierre Percutáneo con ayuda de un Dispositivo tiene Éxito en Niños con Defectos Septales Ventriculares

TAVR Studies Tease Out Influences on Clinical Outcome

TAVR Suitable Even in Patients with Impaired LVEF

La TAVR es Apta Incluso para Pacientes con LVEF Deteriorada

ACC-i2 Scientific Session 2012: Cooperation Key as Practice Changing Results Released

TCTMD’s Top 10 Most Popular News Stories From 2011

Los 10 Artículos Más Populares de TCTMD de 2011

Percutaneous Valve Replacement Stakes Out the Tricuspid

Patient Selection Trends Younger, Less High Risk for Transcatheter Valve Therapy

La Sustitución Percutánea de Válvulas Apuesta por la Tricúspide

La Selección de Pacientes Seleccionados para recibir un Tratamiento de Válvula Transcateter son cada vez Más Jóvenes y de Menor Riesgo

Women Benefit From TAVR as Much as Men, Maybe More

Fewer Vascular Complications as TAVR Evolves

Predictive factors of major VARC vascular complications following trans-femoral transcatheter aortic valve implantation.

FDA approves first artificial aortic heart valve placed without open-heart surgery

TAVI with CoreValve Effective, Safe at 2-Years, Though Mortality a Concern

ACC Scientific Session-i2 Summit 2011: The Devil Is in the Details

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content